Ajax-Loading

Novartis AG - Retained Earnings

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Retained-Earnings" stands at 43.51 Billion United States Dollars as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Retained Earnings" stands at 43.51 Billion USD. This represents an increase of 4.78 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -6.01 percent compared to the value the year prior.
The 1 year change in percent is -6.01.
The 3 year change in percent is -32.59.
The 5 year change in percent is -24.20.

The Serie's long term average value is 60.32 Billion United States Dollars. It's latest available value, on 09/30/2025, is 27.87 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is +9.21%.
The Serie's change in percent from it's maximum value, on 12/31/2018, to it's latest available value, on 09/30/2025, is -47.06%.

Retained Earnings for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Retained Earnings905,699,262,464.00
LogoJohnson & Johnson - Retained Earnings486,508,953,600.00
LogoAbbVie Inc - Retained Earnings399,570,305,024.00
LogoRoche Holding AG - Retained Earnings317,433,206,677.55
LogoAstraZeneca PLC - Retained Earnings280,205,508,085.11